BiotechTube

Placebo + Idebenone

Phase 3Completed
0 watching 0 views this week📈 Rising
69
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Muscular Dystrophy, Duchenne

Conditions

Muscular Dystrophy, Duchenne, Ambulatory Care

Trial Timeline

Jul 1, 2009 → Apr 1, 2014

NCT ID
NCT01027884

About Placebo + Idebenone

Placebo + Idebenone is a phase 3 stage product being developed by Santhera Pharmaceuticals for Muscular Dystrophy, Duchenne. The current trial status is completed. This product is registered under clinical trial identifier NCT01027884. Target conditions include Muscular Dystrophy, Duchenne, Ambulatory Care.

Hype Score Breakdown

Clinical
27
Activity
18
Company
2
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT01027884Phase 3Completed

Competing Products

20 competing products in Muscular Dystrophy, Duchenne

See all competitors
ProductCompanyStageHype Score
Phase 1, SQY51 + Phase 2a, SQY51 (cohort 1) + Phase 2a, SQY51 (cohort 2) + Phase 2a, SQY51 (cohort 3)BiotrialPhase 1/2
33
ENTR-601-44 + ENTR-601-44 - matching placeboEntrada TherapeuticsPhase 1/2
33
ENTR-601-45 + ENTR-601-45 - matching placeboEntrada TherapeuticsPhase 1/2
33
Tadalafil + PlaceboEli LillyPhase 3
77
DS-5141bDaiichi SankyoPhase 2
52
DS-5141bDaiichi SankyoPhase 1/2
41
Bocidelpar + PlaceboAstellas PharmaPhase 1
33
scAAV9.U7.ACCAAstellas PharmaPhase 1/2
41
Placebo + Reldesemtiv 150 mg + Reldesemtiv 450 mgAstellas PharmaPhase 2
52
LY2495655 + PlaceboEli LillyPhase 2
52
HRS-9190; under Inhalational Anesthesia + HRS-9190; under Intravenous Anesthesia + Cisatracurium (under Inhalational Anesthesia). + Cisatracurium (under Intravenous Anesthesia)Jiangsu Hengrui MedicinePhase 2
52
HRS-9190 + HRS-9190 + HRS-9190 + HRS-9190 + Rocuronium + RocuroniumJiangsu Hengrui MedicinePhase 2
52
HRS-9190 + HRS-9190 + HRS-9190Jiangsu Hengrui MedicinePhase 2
52
NS-065/NCNP-01Nippon ShinyakuPhase 2
52
Viltolarsen + PlaceboNippon ShinyakuPhase 3
77
ViltolarsenNippon ShinyakuPhase 2
52
NS-089/NCNP-02 + NS-089/NCNP-02Nippon ShinyakuPhase 2
52
NS-065/NCNP-01Nippon ShinyakuPhase 1
33
NS-050/NCNP-03 + PlaceboNippon ShinyakuPhase 1/2
41
NS-089/NCNP-02Nippon ShinyakuPhase 2
52

Other Products from Santhera Pharmaceuticals

vamorolone 40 mg/mL oral suspensionApproved
77
IdebenoneApproved
77
idebenonePhase 3
69
idebenone + PlaceboPhase 3
69
Idebenone + Idebenone + PlaceboPhase 3
69